MAX BioPharma
Investors Count
2Funding, Valuation & Revenue
2 Fundings
MAX BioPharma's latest funding round was a Grant - II for on October 7, 2013.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/7/2013 | Grant - II | 1 | ||||
Grant |
Date | 10/7/2013 | |
|---|---|---|
Round | Grant - II | Grant |
Amount | ||
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
MAX BioPharma Investors
2 Investors
MAX BioPharma has 2 investors. National Institutes of Health invested in MAX BioPharma's Grant - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/7/2013 | 10/7/2013 | 1 Grant - II | Government | Maryland | ||
Incubator/Accelerator | California |
First funding | 10/7/2013 | |
|---|---|---|
Last Funding | 10/7/2013 | |
Investor | ||
Rounds | 1 Grant - II | |
Board Seats | ||
Type | Government | Incubator/Accelerator |
Location | Maryland | California |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.